Evaluation of SARS-CoV-2 Humoral Response Following Vaccination with ChAdOx1 nCoV-19 (Covishield™) and/or Sinopharm, BBIBP-CorV (Vero cell™)
J Nepal Health Res Counc. 2024 Mar 22;21(3):523-529. doi: 10.33314/jnhrc.v21i3.4634. ABSTRACT BACKGROUND: Billions of doses of COVID-19 vaccine have been introducing in the world to …